nodes	percent_of_prediction	percent_of_DWPC	metapath
Rosiglitazone—PPARG—pancreatic cancer	0.34	1	CbGaD
Rosiglitazone—Tripelennamine—Tamoxifen—pancreatic cancer	0.216	1	CrCrCtD
Rosiglitazone—CYP2A6—Tamoxifen—pancreatic cancer	0.0396	0.116	CbGbCtD
Rosiglitazone—SLCO1B1—Irinotecan—pancreatic cancer	0.0354	0.104	CbGbCtD
Rosiglitazone—CYP2A6—Fluorouracil—pancreatic cancer	0.0292	0.0857	CbGbCtD
Rosiglitazone—ALB—Erlotinib—pancreatic cancer	0.0215	0.0631	CbGbCtD
Rosiglitazone—CYP2C8—Tamoxifen—pancreatic cancer	0.0195	0.0573	CbGbCtD
Rosiglitazone—ALB—Irinotecan—pancreatic cancer	0.0194	0.057	CbGbCtD
Rosiglitazone—CYP1A2—Dacarbazine—pancreatic cancer	0.019	0.0558	CbGbCtD
Rosiglitazone—ALB—Fluorouracil—pancreatic cancer	0.0186	0.0547	CbGbCtD
Rosiglitazone—CYP2C8—Erlotinib—pancreatic cancer	0.0166	0.0487	CbGbCtD
Rosiglitazone—CYP2C19—Tamoxifen—pancreatic cancer	0.0164	0.0481	CbGbCtD
Rosiglitazone—CYP1A2—Tamoxifen—pancreatic cancer	0.0151	0.0444	CbGbCtD
Rosiglitazone—CYP2C8—Fluorouracil—pancreatic cancer	0.0144	0.0422	CbGbCtD
Rosiglitazone—CYP2C9—Tamoxifen—pancreatic cancer	0.0136	0.04	CbGbCtD
Rosiglitazone—CYP1A2—Erlotinib—pancreatic cancer	0.0128	0.0377	CbGbCtD
Rosiglitazone—CYP2D6—Tamoxifen—pancreatic cancer	0.0124	0.0366	CbGbCtD
Rosiglitazone—CYP1A2—Fluorouracil—pancreatic cancer	0.0111	0.0327	CbGbCtD
Rosiglitazone—CYP2D6—Erlotinib—pancreatic cancer	0.0106	0.0311	CbGbCtD
Rosiglitazone—CYP2C9—Fluorouracil—pancreatic cancer	0.01	0.0295	CbGbCtD
Rosiglitazone—CYP2D6—Doxorubicin—pancreatic cancer	0.00522	0.0153	CbGbCtD
Rosiglitazone—PPARG—Topotecan—Irinotecan—pancreatic cancer	0.00232	1	CbGdCrCtD
Rosiglitazone—Pioglitazone—PPARG—pancreatic cancer	0.00181	1	CrCbGaD
Rosiglitazone—Anaemia—Sunitinib—pancreatic cancer	0.000258	0.00279	CcSEcCtD
Rosiglitazone—Thrombocytopenia—Erlotinib—pancreatic cancer	0.000257	0.00279	CcSEcCtD
Rosiglitazone—Angioedema—Sunitinib—pancreatic cancer	0.000255	0.00276	CcSEcCtD
Rosiglitazone—Oedema peripheral—Gemcitabine—pancreatic cancer	0.000253	0.00274	CcSEcCtD
Rosiglitazone—Connective tissue disorder—Gemcitabine—pancreatic cancer	0.000252	0.00273	CcSEcCtD
Rosiglitazone—Leukopenia—Sunitinib—pancreatic cancer	0.000249	0.0027	CcSEcCtD
Rosiglitazone—Hyperbilirubinaemia—Doxorubicin—pancreatic cancer	0.000249	0.0027	CcSEcCtD
Rosiglitazone—Cardiac disorder—Irinotecan—pancreatic cancer	0.000245	0.00265	CcSEcCtD
Rosiglitazone—Erythema multiforme—Gemcitabine—pancreatic cancer	0.000243	0.00263	CcSEcCtD
Rosiglitazone—Musculoskeletal discomfort—Tamoxifen—pancreatic cancer	0.000242	0.00262	CcSEcCtD
Rosiglitazone—Hypertension—Sunitinib—pancreatic cancer	0.000241	0.00261	CcSEcCtD
Rosiglitazone—Musculoskeletal discomfort—Erlotinib—pancreatic cancer	0.000239	0.00259	CcSEcCtD
Rosiglitazone—Cardiac disorder—Gemcitabine—pancreatic cancer	0.000238	0.00258	CcSEcCtD
Rosiglitazone—Immune system disorder—Irinotecan—pancreatic cancer	0.000238	0.00258	CcSEcCtD
Rosiglitazone—Myalgia—Sunitinib—pancreatic cancer	0.000237	0.00257	CcSEcCtD
Rosiglitazone—Arthralgia—Sunitinib—pancreatic cancer	0.000237	0.00257	CcSEcCtD
Rosiglitazone—Nasopharyngitis—Docetaxel—pancreatic cancer	0.000236	0.00255	CcSEcCtD
Rosiglitazone—Fluid retention—Epirubicin—pancreatic cancer	0.000232	0.00252	CcSEcCtD
Rosiglitazone—Immune system disorder—Gemcitabine—pancreatic cancer	0.000232	0.00251	CcSEcCtD
Rosiglitazone—Gastrointestinal disorder—Tamoxifen—pancreatic cancer	0.000229	0.00248	CcSEcCtD
Rosiglitazone—Fatigue—Tamoxifen—pancreatic cancer	0.000229	0.00248	CcSEcCtD
Rosiglitazone—Oedema—Sunitinib—pancreatic cancer	0.000227	0.00246	CcSEcCtD
Rosiglitazone—Constipation—Tamoxifen—pancreatic cancer	0.000227	0.00246	CcSEcCtD
Rosiglitazone—Gastrointestinal disorder—Erlotinib—pancreatic cancer	0.000227	0.00246	CcSEcCtD
Rosiglitazone—Fatigue—Erlotinib—pancreatic cancer	0.000227	0.00245	CcSEcCtD
Rosiglitazone—Infection—Sunitinib—pancreatic cancer	0.000226	0.00245	CcSEcCtD
Rosiglitazone—Constipation—Erlotinib—pancreatic cancer	0.000225	0.00243	CcSEcCtD
Rosiglitazone—Nervous system disorder—Sunitinib—pancreatic cancer	0.000223	0.00242	CcSEcCtD
Rosiglitazone—Thrombocytopenia—Sunitinib—pancreatic cancer	0.000223	0.00241	CcSEcCtD
Rosiglitazone—Back pain—Irinotecan—pancreatic cancer	0.000222	0.0024	CcSEcCtD
Rosiglitazone—Pulmonary oedema—Epirubicin—pancreatic cancer	0.000218	0.00236	CcSEcCtD
Rosiglitazone—Back pain—Gemcitabine—pancreatic cancer	0.000216	0.00234	CcSEcCtD
Rosiglitazone—Fluid retention—Doxorubicin—pancreatic cancer	0.000215	0.00233	CcSEcCtD
Rosiglitazone—Anaemia—Irinotecan—pancreatic cancer	0.000212	0.0023	CcSEcCtD
Rosiglitazone—Urticaria—Tamoxifen—pancreatic cancer	0.000211	0.00228	CcSEcCtD
Rosiglitazone—Weight increased—Docetaxel—pancreatic cancer	0.000207	0.00224	CcSEcCtD
Rosiglitazone—Musculoskeletal discomfort—Sunitinib—pancreatic cancer	0.000207	0.00224	CcSEcCtD
Rosiglitazone—Anaemia—Gemcitabine—pancreatic cancer	0.000207	0.00224	CcSEcCtD
Rosiglitazone—Leukopenia—Irinotecan—pancreatic cancer	0.000206	0.00223	CcSEcCtD
Rosiglitazone—Diabetes mellitus—Epirubicin—pancreatic cancer	0.000204	0.00221	CcSEcCtD
Rosiglitazone—Hepatic function abnormal—Epirubicin—pancreatic cancer	0.000203	0.0022	CcSEcCtD
Rosiglitazone—Anaemia—Fluorouracil—pancreatic cancer	0.000203	0.0022	CcSEcCtD
Rosiglitazone—Pulmonary oedema—Doxorubicin—pancreatic cancer	0.000202	0.00218	CcSEcCtD
Rosiglitazone—Stevens-Johnson syndrome—Docetaxel—pancreatic cancer	0.000201	0.00218	CcSEcCtD
Rosiglitazone—Acute coronary syndrome—Docetaxel—pancreatic cancer	0.0002	0.00217	CcSEcCtD
Rosiglitazone—Leukopenia—Gemcitabine—pancreatic cancer	0.0002	0.00217	CcSEcCtD
Rosiglitazone—Myocardial infarction—Docetaxel—pancreatic cancer	0.000199	0.00216	CcSEcCtD
Rosiglitazone—Hypertension—Irinotecan—pancreatic cancer	0.000198	0.00215	CcSEcCtD
Rosiglitazone—Hepatic failure—Epirubicin—pancreatic cancer	0.000198	0.00214	CcSEcCtD
Rosiglitazone—Leukopenia—Fluorouracil—pancreatic cancer	0.000197	0.00213	CcSEcCtD
Rosiglitazone—Gastrointestinal disorder—Sunitinib—pancreatic cancer	0.000196	0.00213	CcSEcCtD
Rosiglitazone—Fatigue—Sunitinib—pancreatic cancer	0.000196	0.00212	CcSEcCtD
Rosiglitazone—Cardiac failure congestive—Epirubicin—pancreatic cancer	0.000196	0.00212	CcSEcCtD
Rosiglitazone—Constipation—Sunitinib—pancreatic cancer	0.000195	0.00211	CcSEcCtD
Rosiglitazone—Hypertension—Gemcitabine—pancreatic cancer	0.000193	0.00209	CcSEcCtD
Rosiglitazone—Hepatobiliary disease—Docetaxel—pancreatic cancer	0.000192	0.00208	CcSEcCtD
Rosiglitazone—Asthenia—Tamoxifen—pancreatic cancer	0.000191	0.00206	CcSEcCtD
Rosiglitazone—Arthralgia—Gemcitabine—pancreatic cancer	0.00019	0.00206	CcSEcCtD
Rosiglitazone—Myalgia—Gemcitabine—pancreatic cancer	0.00019	0.00206	CcSEcCtD
Rosiglitazone—Increased appetite—Epirubicin—pancreatic cancer	0.000189	0.00205	CcSEcCtD
Rosiglitazone—Diabetes mellitus—Doxorubicin—pancreatic cancer	0.000189	0.00205	CcSEcCtD
Rosiglitazone—Asthenia—Erlotinib—pancreatic cancer	0.000189	0.00204	CcSEcCtD
Rosiglitazone—Hepatic function abnormal—Doxorubicin—pancreatic cancer	0.000188	0.00204	CcSEcCtD
Rosiglitazone—Pruritus—Tamoxifen—pancreatic cancer	0.000188	0.00203	CcSEcCtD
Rosiglitazone—Anaphylactic shock—Irinotecan—pancreatic cancer	0.000187	0.00203	CcSEcCtD
Rosiglitazone—Oedema—Irinotecan—pancreatic cancer	0.000187	0.00203	CcSEcCtD
Rosiglitazone—Myalgia—Fluorouracil—pancreatic cancer	0.000187	0.00203	CcSEcCtD
Rosiglitazone—Infection—Irinotecan—pancreatic cancer	0.000186	0.00202	CcSEcCtD
Rosiglitazone—Pruritus—Erlotinib—pancreatic cancer	0.000186	0.00201	CcSEcCtD
Rosiglitazone—Nervous system disorder—Irinotecan—pancreatic cancer	0.000184	0.00199	CcSEcCtD
Rosiglitazone—Thrombocytopenia—Irinotecan—pancreatic cancer	0.000183	0.00199	CcSEcCtD
Rosiglitazone—Hepatic failure—Doxorubicin—pancreatic cancer	0.000183	0.00198	CcSEcCtD
Rosiglitazone—Oedema—Gemcitabine—pancreatic cancer	0.000183	0.00198	CcSEcCtD
Rosiglitazone—Anaphylactic shock—Gemcitabine—pancreatic cancer	0.000183	0.00198	CcSEcCtD
Rosiglitazone—Hepatitis—Docetaxel—pancreatic cancer	0.000182	0.00197	CcSEcCtD
Rosiglitazone—Hypoglycaemia—Epirubicin—pancreatic cancer	0.000182	0.00197	CcSEcCtD
Rosiglitazone—Cardiac failure—Epirubicin—pancreatic cancer	0.000182	0.00197	CcSEcCtD
Rosiglitazone—Diarrhoea—Tamoxifen—pancreatic cancer	0.000182	0.00197	CcSEcCtD
Rosiglitazone—Cerebrovascular accident—Epirubicin—pancreatic cancer	0.000181	0.00196	CcSEcCtD
Rosiglitazone—Cardiac failure congestive—Doxorubicin—pancreatic cancer	0.000181	0.00196	CcSEcCtD
Rosiglitazone—Infection—Gemcitabine—pancreatic cancer	0.000181	0.00196	CcSEcCtD
Rosiglitazone—Diarrhoea—Erlotinib—pancreatic cancer	0.00018	0.00195	CcSEcCtD
Rosiglitazone—Oedema peripheral—Docetaxel—pancreatic cancer	0.00018	0.00194	CcSEcCtD
Rosiglitazone—Anaphylactic shock—Fluorouracil—pancreatic cancer	0.000179	0.00194	CcSEcCtD
Rosiglitazone—Oedema—Fluorouracil—pancreatic cancer	0.000179	0.00194	CcSEcCtD
Rosiglitazone—Connective tissue disorder—Docetaxel—pancreatic cancer	0.000179	0.00194	CcSEcCtD
Rosiglitazone—Nervous system disorder—Gemcitabine—pancreatic cancer	0.000179	0.00194	CcSEcCtD
Rosiglitazone—Thrombocytopenia—Gemcitabine—pancreatic cancer	0.000179	0.00193	CcSEcCtD
Rosiglitazone—Infection—Fluorouracil—pancreatic cancer	0.000178	0.00193	CcSEcCtD
Rosiglitazone—Nervous system disorder—Fluorouracil—pancreatic cancer	0.000176	0.00191	CcSEcCtD
Rosiglitazone—Thrombocytopenia—Fluorouracil—pancreatic cancer	0.000176	0.0019	CcSEcCtD
Rosiglitazone—Dizziness—Tamoxifen—pancreatic cancer	0.000176	0.0019	CcSEcCtD
Rosiglitazone—Increased appetite—Doxorubicin—pancreatic cancer	0.000175	0.0019	CcSEcCtD
Rosiglitazone—Dizziness—Erlotinib—pancreatic cancer	0.000174	0.00188	CcSEcCtD
Rosiglitazone—Erythema multiforme—Docetaxel—pancreatic cancer	0.000172	0.00187	CcSEcCtD
Rosiglitazone—Eye disorder—Docetaxel—pancreatic cancer	0.00017	0.00184	CcSEcCtD
Rosiglitazone—Cardiac disorder—Docetaxel—pancreatic cancer	0.000169	0.00183	CcSEcCtD
Rosiglitazone—Hypoglycaemia—Doxorubicin—pancreatic cancer	0.000169	0.00182	CcSEcCtD
Rosiglitazone—Cardiac failure—Doxorubicin—pancreatic cancer	0.000169	0.00182	CcSEcCtD
Rosiglitazone—Cerebrovascular accident—Doxorubicin—pancreatic cancer	0.000168	0.00182	CcSEcCtD
Rosiglitazone—Rash—Tamoxifen—pancreatic cancer	0.000167	0.00181	CcSEcCtD
Rosiglitazone—Dermatitis—Tamoxifen—pancreatic cancer	0.000167	0.00181	CcSEcCtD
Rosiglitazone—Headache—Tamoxifen—pancreatic cancer	0.000166	0.0018	CcSEcCtD
Rosiglitazone—Musculoskeletal discomfort—Gemcitabine—pancreatic cancer	0.000166	0.0018	CcSEcCtD
Rosiglitazone—Rash—Erlotinib—pancreatic cancer	0.000166	0.00179	CcSEcCtD
Rosiglitazone—Dermatitis—Erlotinib—pancreatic cancer	0.000166	0.00179	CcSEcCtD
Rosiglitazone—Immune system disorder—Docetaxel—pancreatic cancer	0.000165	0.00178	CcSEcCtD
Rosiglitazone—Headache—Erlotinib—pancreatic cancer	0.000165	0.00178	CcSEcCtD
Rosiglitazone—Musculoskeletal discomfort—Fluorouracil—pancreatic cancer	0.000164	0.00177	CcSEcCtD
Rosiglitazone—Asthenia—Sunitinib—pancreatic cancer	0.000163	0.00177	CcSEcCtD
Rosiglitazone—Gastrointestinal disorder—Irinotecan—pancreatic cancer	0.000162	0.00175	CcSEcCtD
Rosiglitazone—Fatigue—Irinotecan—pancreatic cancer	0.000162	0.00175	CcSEcCtD
Rosiglitazone—Pruritus—Sunitinib—pancreatic cancer	0.000161	0.00174	CcSEcCtD
Rosiglitazone—Constipation—Irinotecan—pancreatic cancer	0.00016	0.00173	CcSEcCtD
Rosiglitazone—Nasopharyngitis—Epirubicin—pancreatic cancer	0.000159	0.00172	CcSEcCtD
Rosiglitazone—Malnutrition—Docetaxel—pancreatic cancer	0.000159	0.00172	CcSEcCtD
Rosiglitazone—Nausea—Tamoxifen—pancreatic cancer	0.000158	0.00171	CcSEcCtD
Rosiglitazone—Gastrointestinal disorder—Gemcitabine—pancreatic cancer	0.000158	0.00171	CcSEcCtD
Rosiglitazone—Fatigue—Gemcitabine—pancreatic cancer	0.000157	0.0017	CcSEcCtD
Rosiglitazone—Constipation—Gemcitabine—pancreatic cancer	0.000156	0.00169	CcSEcCtD
Rosiglitazone—Nausea—Erlotinib—pancreatic cancer	0.000156	0.00169	CcSEcCtD
Rosiglitazone—Diarrhoea—Sunitinib—pancreatic cancer	0.000156	0.00169	CcSEcCtD
Rosiglitazone—Gastrointestinal disorder—Fluorouracil—pancreatic cancer	0.000155	0.00168	CcSEcCtD
Rosiglitazone—Back pain—Docetaxel—pancreatic cancer	0.000154	0.00166	CcSEcCtD
Rosiglitazone—Dizziness—Sunitinib—pancreatic cancer	0.00015	0.00163	CcSEcCtD
Rosiglitazone—Nasopharyngitis—Doxorubicin—pancreatic cancer	0.000147	0.00159	CcSEcCtD
Rosiglitazone—Anaemia—Docetaxel—pancreatic cancer	0.000147	0.00159	CcSEcCtD
Rosiglitazone—Rash—Sunitinib—pancreatic cancer	0.000143	0.00155	CcSEcCtD
Rosiglitazone—Dermatitis—Sunitinib—pancreatic cancer	0.000143	0.00155	CcSEcCtD
Rosiglitazone—Upper respiratory tract infection—Epirubicin—pancreatic cancer	0.000143	0.00155	CcSEcCtD
Rosiglitazone—Urticaria—Fluorouracil—pancreatic cancer	0.000143	0.00154	CcSEcCtD
Rosiglitazone—Headache—Sunitinib—pancreatic cancer	0.000143	0.00154	CcSEcCtD
Rosiglitazone—Leukopenia—Docetaxel—pancreatic cancer	0.000142	0.00154	CcSEcCtD
Rosiglitazone—Weight increased—Epirubicin—pancreatic cancer	0.00014	0.00151	CcSEcCtD
Rosiglitazone—Hyperglycaemia—Epirubicin—pancreatic cancer	0.000139	0.0015	CcSEcCtD
Rosiglitazone—Hypertension—Docetaxel—pancreatic cancer	0.000137	0.00148	CcSEcCtD
Rosiglitazone—Stevens-Johnson syndrome—Epirubicin—pancreatic cancer	0.000136	0.00147	CcSEcCtD
Rosiglitazone—Arthralgia—Docetaxel—pancreatic cancer	0.000135	0.00146	CcSEcCtD
Rosiglitazone—Myalgia—Docetaxel—pancreatic cancer	0.000135	0.00146	CcSEcCtD
Rosiglitazone—Nausea—Sunitinib—pancreatic cancer	0.000135	0.00146	CcSEcCtD
Rosiglitazone—Asthenia—Irinotecan—pancreatic cancer	0.000134	0.00146	CcSEcCtD
Rosiglitazone—Upper respiratory tract infection—Doxorubicin—pancreatic cancer	0.000132	0.00143	CcSEcCtD
Rosiglitazone—Asthenia—Gemcitabine—pancreatic cancer	0.000131	0.00142	CcSEcCtD
Rosiglitazone—Hepatobiliary disease—Epirubicin—pancreatic cancer	0.00013	0.0014	CcSEcCtD
Rosiglitazone—Oedema—Docetaxel—pancreatic cancer	0.00013	0.0014	CcSEcCtD
Rosiglitazone—Anaphylactic shock—Docetaxel—pancreatic cancer	0.00013	0.0014	CcSEcCtD
Rosiglitazone—Weight increased—Doxorubicin—pancreatic cancer	0.000129	0.0014	CcSEcCtD
Rosiglitazone—Pruritus—Gemcitabine—pancreatic cancer	0.000129	0.0014	CcSEcCtD
Rosiglitazone—Infection—Docetaxel—pancreatic cancer	0.000129	0.00139	CcSEcCtD
Rosiglitazone—Sinusitis—Epirubicin—pancreatic cancer	0.000129	0.00139	CcSEcCtD
Rosiglitazone—Hyperglycaemia—Doxorubicin—pancreatic cancer	0.000128	0.00139	CcSEcCtD
Rosiglitazone—Diarrhoea—Irinotecan—pancreatic cancer	0.000128	0.00139	CcSEcCtD
Rosiglitazone—Nervous system disorder—Docetaxel—pancreatic cancer	0.000127	0.00138	CcSEcCtD
Rosiglitazone—Pruritus—Fluorouracil—pancreatic cancer	0.000127	0.00137	CcSEcCtD
Rosiglitazone—Thrombocytopenia—Docetaxel—pancreatic cancer	0.000127	0.00137	CcSEcCtD
Rosiglitazone—Stevens-Johnson syndrome—Doxorubicin—pancreatic cancer	0.000126	0.00136	CcSEcCtD
Rosiglitazone—Diarrhoea—Gemcitabine—pancreatic cancer	0.000125	0.00135	CcSEcCtD
Rosiglitazone—Dizziness—Irinotecan—pancreatic cancer	0.000124	0.00134	CcSEcCtD
Rosiglitazone—Hepatitis—Epirubicin—pancreatic cancer	0.000123	0.00133	CcSEcCtD
Rosiglitazone—Diarrhoea—Fluorouracil—pancreatic cancer	0.000123	0.00133	CcSEcCtD
Rosiglitazone—Oedema peripheral—Epirubicin—pancreatic cancer	0.000121	0.00131	CcSEcCtD
Rosiglitazone—Connective tissue disorder—Epirubicin—pancreatic cancer	0.000121	0.00131	CcSEcCtD
Rosiglitazone—Hepatobiliary disease—Doxorubicin—pancreatic cancer	0.00012	0.0013	CcSEcCtD
Rosiglitazone—Sinusitis—Doxorubicin—pancreatic cancer	0.000119	0.00129	CcSEcCtD
Rosiglitazone—Dizziness—Fluorouracil—pancreatic cancer	0.000119	0.00128	CcSEcCtD
Rosiglitazone—Rash—Irinotecan—pancreatic cancer	0.000118	0.00128	CcSEcCtD
Rosiglitazone—Dermatitis—Irinotecan—pancreatic cancer	0.000118	0.00128	CcSEcCtD
Rosiglitazone—Musculoskeletal discomfort—Docetaxel—pancreatic cancer	0.000118	0.00128	CcSEcCtD
Rosiglitazone—Headache—Irinotecan—pancreatic cancer	0.000117	0.00127	CcSEcCtD
Rosiglitazone—Erythema multiforme—Epirubicin—pancreatic cancer	0.000116	0.00126	CcSEcCtD
Rosiglitazone—Rash—Gemcitabine—pancreatic cancer	0.000115	0.00125	CcSEcCtD
Rosiglitazone—Dermatitis—Gemcitabine—pancreatic cancer	0.000115	0.00124	CcSEcCtD
Rosiglitazone—Eye disorder—Epirubicin—pancreatic cancer	0.000115	0.00124	CcSEcCtD
Rosiglitazone—Headache—Gemcitabine—pancreatic cancer	0.000114	0.00124	CcSEcCtD
Rosiglitazone—Cardiac disorder—Epirubicin—pancreatic cancer	0.000114	0.00124	CcSEcCtD
Rosiglitazone—Hepatitis—Doxorubicin—pancreatic cancer	0.000114	0.00123	CcSEcCtD
Rosiglitazone—Rash—Fluorouracil—pancreatic cancer	0.000113	0.00123	CcSEcCtD
Rosiglitazone—Dermatitis—Fluorouracil—pancreatic cancer	0.000113	0.00122	CcSEcCtD
Rosiglitazone—Headache—Fluorouracil—pancreatic cancer	0.000112	0.00122	CcSEcCtD
Rosiglitazone—Oedema peripheral—Doxorubicin—pancreatic cancer	0.000112	0.00121	CcSEcCtD
Rosiglitazone—Gastrointestinal disorder—Docetaxel—pancreatic cancer	0.000112	0.00121	CcSEcCtD
Rosiglitazone—Connective tissue disorder—Doxorubicin—pancreatic cancer	0.000112	0.00121	CcSEcCtD
Rosiglitazone—Fatigue—Docetaxel—pancreatic cancer	0.000112	0.00121	CcSEcCtD
Rosiglitazone—Nausea—Irinotecan—pancreatic cancer	0.000111	0.00121	CcSEcCtD
Rosiglitazone—Immune system disorder—Epirubicin—pancreatic cancer	0.000111	0.0012	CcSEcCtD
Rosiglitazone—Constipation—Docetaxel—pancreatic cancer	0.000111	0.0012	CcSEcCtD
Rosiglitazone—Nausea—Gemcitabine—pancreatic cancer	0.000108	0.00117	CcSEcCtD
Rosiglitazone—Erythema multiforme—Doxorubicin—pancreatic cancer	0.000108	0.00116	CcSEcCtD
Rosiglitazone—Malnutrition—Epirubicin—pancreatic cancer	0.000107	0.00116	CcSEcCtD
Rosiglitazone—Nausea—Fluorouracil—pancreatic cancer	0.000107	0.00115	CcSEcCtD
Rosiglitazone—Eye disorder—Doxorubicin—pancreatic cancer	0.000106	0.00115	CcSEcCtD
Rosiglitazone—Cardiac disorder—Doxorubicin—pancreatic cancer	0.000106	0.00114	CcSEcCtD
Rosiglitazone—Back pain—Epirubicin—pancreatic cancer	0.000104	0.00112	CcSEcCtD
Rosiglitazone—Immune system disorder—Doxorubicin—pancreatic cancer	0.000103	0.00111	CcSEcCtD
Rosiglitazone—Malnutrition—Doxorubicin—pancreatic cancer	9.9e-05	0.00107	CcSEcCtD
Rosiglitazone—Anaemia—Epirubicin—pancreatic cancer	9.89e-05	0.00107	CcSEcCtD
Rosiglitazone—Leukopenia—Epirubicin—pancreatic cancer	9.58e-05	0.00104	CcSEcCtD
Rosiglitazone—Back pain—Doxorubicin—pancreatic cancer	9.58e-05	0.00104	CcSEcCtD
Rosiglitazone—Asthenia—Docetaxel—pancreatic cancer	9.29e-05	0.00101	CcSEcCtD
Rosiglitazone—Hypertension—Epirubicin—pancreatic cancer	9.24e-05	0.001	CcSEcCtD
Rosiglitazone—Pruritus—Docetaxel—pancreatic cancer	9.16e-05	0.000992	CcSEcCtD
Rosiglitazone—Anaemia—Doxorubicin—pancreatic cancer	9.15e-05	0.000991	CcSEcCtD
Rosiglitazone—Arthralgia—Epirubicin—pancreatic cancer	9.11e-05	0.000987	CcSEcCtD
Rosiglitazone—Myalgia—Epirubicin—pancreatic cancer	9.11e-05	0.000987	CcSEcCtD
Rosiglitazone—Leukopenia—Doxorubicin—pancreatic cancer	8.87e-05	0.00096	CcSEcCtD
Rosiglitazone—Diarrhoea—Docetaxel—pancreatic cancer	8.86e-05	0.00096	CcSEcCtD
Rosiglitazone—Anaphylactic shock—Epirubicin—pancreatic cancer	8.74e-05	0.000946	CcSEcCtD
Rosiglitazone—Oedema—Epirubicin—pancreatic cancer	8.74e-05	0.000946	CcSEcCtD
Rosiglitazone—Infection—Epirubicin—pancreatic cancer	8.68e-05	0.00094	CcSEcCtD
Rosiglitazone—Nervous system disorder—Epirubicin—pancreatic cancer	8.57e-05	0.000928	CcSEcCtD
Rosiglitazone—Dizziness—Docetaxel—pancreatic cancer	8.57e-05	0.000927	CcSEcCtD
Rosiglitazone—Thrombocytopenia—Epirubicin—pancreatic cancer	8.55e-05	0.000926	CcSEcCtD
Rosiglitazone—Hypertension—Doxorubicin—pancreatic cancer	8.55e-05	0.000926	CcSEcCtD
Rosiglitazone—Arthralgia—Doxorubicin—pancreatic cancer	8.43e-05	0.000913	CcSEcCtD
Rosiglitazone—Myalgia—Doxorubicin—pancreatic cancer	8.43e-05	0.000913	CcSEcCtD
Rosiglitazone—Rash—Docetaxel—pancreatic cancer	8.17e-05	0.000884	CcSEcCtD
Rosiglitazone—Dermatitis—Docetaxel—pancreatic cancer	8.16e-05	0.000883	CcSEcCtD
Rosiglitazone—Headache—Docetaxel—pancreatic cancer	8.11e-05	0.000879	CcSEcCtD
Rosiglitazone—Anaphylactic shock—Doxorubicin—pancreatic cancer	8.08e-05	0.000875	CcSEcCtD
Rosiglitazone—Oedema—Doxorubicin—pancreatic cancer	8.08e-05	0.000875	CcSEcCtD
Rosiglitazone—Infection—Doxorubicin—pancreatic cancer	8.03e-05	0.00087	CcSEcCtD
Rosiglitazone—Musculoskeletal discomfort—Epirubicin—pancreatic cancer	7.96e-05	0.000862	CcSEcCtD
Rosiglitazone—Nervous system disorder—Doxorubicin—pancreatic cancer	7.93e-05	0.000858	CcSEcCtD
Rosiglitazone—Thrombocytopenia—Doxorubicin—pancreatic cancer	7.91e-05	0.000857	CcSEcCtD
Rosiglitazone—Nausea—Docetaxel—pancreatic cancer	7.69e-05	0.000833	CcSEcCtD
Rosiglitazone—Gastrointestinal disorder—Epirubicin—pancreatic cancer	7.54e-05	0.000817	CcSEcCtD
Rosiglitazone—Fatigue—Epirubicin—pancreatic cancer	7.53e-05	0.000816	CcSEcCtD
Rosiglitazone—Constipation—Epirubicin—pancreatic cancer	7.47e-05	0.000809	CcSEcCtD
Rosiglitazone—Musculoskeletal discomfort—Doxorubicin—pancreatic cancer	7.36e-05	0.000797	CcSEcCtD
Rosiglitazone—Gastrointestinal disorder—Doxorubicin—pancreatic cancer	6.98e-05	0.000756	CcSEcCtD
Rosiglitazone—Fatigue—Doxorubicin—pancreatic cancer	6.97e-05	0.000755	CcSEcCtD
Rosiglitazone—Urticaria—Epirubicin—pancreatic cancer	6.94e-05	0.000751	CcSEcCtD
Rosiglitazone—Constipation—Doxorubicin—pancreatic cancer	6.91e-05	0.000748	CcSEcCtD
Rosiglitazone—Urticaria—Doxorubicin—pancreatic cancer	6.42e-05	0.000695	CcSEcCtD
Rosiglitazone—Asthenia—Epirubicin—pancreatic cancer	6.27e-05	0.000679	CcSEcCtD
Rosiglitazone—Pruritus—Epirubicin—pancreatic cancer	6.18e-05	0.000669	CcSEcCtD
Rosiglitazone—Diarrhoea—Epirubicin—pancreatic cancer	5.98e-05	0.000647	CcSEcCtD
Rosiglitazone—Asthenia—Doxorubicin—pancreatic cancer	5.8e-05	0.000628	CcSEcCtD
Rosiglitazone—Dizziness—Epirubicin—pancreatic cancer	5.78e-05	0.000626	CcSEcCtD
Rosiglitazone—Pruritus—Doxorubicin—pancreatic cancer	5.72e-05	0.000619	CcSEcCtD
Rosiglitazone—Diarrhoea—Doxorubicin—pancreatic cancer	5.53e-05	0.000599	CcSEcCtD
Rosiglitazone—Rash—Epirubicin—pancreatic cancer	5.51e-05	0.000596	CcSEcCtD
Rosiglitazone—Dermatitis—Epirubicin—pancreatic cancer	5.5e-05	0.000596	CcSEcCtD
Rosiglitazone—Headache—Epirubicin—pancreatic cancer	5.47e-05	0.000593	CcSEcCtD
Rosiglitazone—Dizziness—Doxorubicin—pancreatic cancer	5.35e-05	0.000579	CcSEcCtD
Rosiglitazone—Nausea—Epirubicin—pancreatic cancer	5.19e-05	0.000562	CcSEcCtD
Rosiglitazone—Rash—Doxorubicin—pancreatic cancer	5.1e-05	0.000552	CcSEcCtD
Rosiglitazone—Dermatitis—Doxorubicin—pancreatic cancer	5.09e-05	0.000551	CcSEcCtD
Rosiglitazone—Headache—Doxorubicin—pancreatic cancer	5.06e-05	0.000548	CcSEcCtD
Rosiglitazone—Nausea—Doxorubicin—pancreatic cancer	4.8e-05	0.00052	CcSEcCtD
Rosiglitazone—CYP2A6—Metabolism—DPYD—pancreatic cancer	4.93e-06	0.000714	CbGpPWpGaD
Rosiglitazone—PTGS1—Metabolism of lipids and lipoproteins—PIK3CG—pancreatic cancer	4.9e-06	0.000709	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism—ARG2—pancreatic cancer	4.86e-06	0.000703	CbGpPWpGaD
Rosiglitazone—SLCO1B1—Metabolism of lipids and lipoproteins—PIK3CD—pancreatic cancer	4.84e-06	0.0007	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism—ARG2—pancreatic cancer	4.83e-06	0.000699	CbGpPWpGaD
Rosiglitazone—PPARG—Developmental Biology—SRC—pancreatic cancer	4.81e-06	0.000696	CbGpPWpGaD
Rosiglitazone—ACSL4—Metabolism—PIK3CA—pancreatic cancer	4.74e-06	0.000686	CbGpPWpGaD
Rosiglitazone—PTGS1—Metabolism of lipids and lipoproteins—PPARG—pancreatic cancer	4.73e-06	0.000684	CbGpPWpGaD
Rosiglitazone—PPARG—Developmental Biology—VEGFA—pancreatic cancer	4.68e-06	0.000677	CbGpPWpGaD
Rosiglitazone—CYP2A6—Metabolism—SLC2A2—pancreatic cancer	4.68e-06	0.000677	CbGpPWpGaD
Rosiglitazone—PPARG—Developmental Biology—STAT3—pancreatic cancer	4.64e-06	0.000671	CbGpPWpGaD
Rosiglitazone—PPARG—Metabolism of lipids and lipoproteins—PTEN—pancreatic cancer	4.63e-06	0.00067	CbGpPWpGaD
Rosiglitazone—PPARG—Developmental Biology—NRAS—pancreatic cancer	4.63e-06	0.000669	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—PRSS1—pancreatic cancer	4.6e-06	0.000666	CbGpPWpGaD
Rosiglitazone—PPARG—Generic Transcription Pathway—MYC—pancreatic cancer	4.58e-06	0.000662	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—PRSS1—pancreatic cancer	4.56e-06	0.00066	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism—ARG2—pancreatic cancer	4.34e-06	0.000628	CbGpPWpGaD
Rosiglitazone—SLCO1B1—Metabolism—CD44—pancreatic cancer	4.31e-06	0.000623	CbGpPWpGaD
Rosiglitazone—PTGS1—Metabolism of lipids and lipoproteins—PIK3CD—pancreatic cancer	4.31e-06	0.000623	CbGpPWpGaD
Rosiglitazone—PPARG—Developmental Biology—TGFB1—pancreatic cancer	4.3e-06	0.000622	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism—TYMP—pancreatic cancer	4.25e-06	0.000615	CbGpPWpGaD
Rosiglitazone—PPARG—Metabolism—TYMS—pancreatic cancer	4.24e-06	0.000614	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism—TYMP—pancreatic cancer	4.22e-06	0.000611	CbGpPWpGaD
Rosiglitazone—SLCO1B1—Metabolism of lipids and lipoproteins—PIK3CB—pancreatic cancer	4.22e-06	0.00061	CbGpPWpGaD
Rosiglitazone—PPARG—Developmental Biology—EGFR—pancreatic cancer	4.21e-06	0.00061	CbGpPWpGaD
Rosiglitazone—SLCO1B1—Metabolism of lipids and lipoproteins—PTGS2—pancreatic cancer	4.18e-06	0.000605	CbGpPWpGaD
Rosiglitazone—SLCO1B1—Metabolism—GCG—pancreatic cancer	4.13e-06	0.000598	CbGpPWpGaD
Rosiglitazone—ALB—Platelet activation, signaling and aggregation—SRC—pancreatic cancer	4.12e-06	0.000596	CbGpPWpGaD
Rosiglitazone—PPARG—Gene Expression—NOTCH1—pancreatic cancer	4.1e-06	0.000592	CbGpPWpGaD
Rosiglitazone—PPARG—Developmental Biology—TNF—pancreatic cancer	4.01e-06	0.000581	CbGpPWpGaD
Rosiglitazone—ALB—Platelet activation, signaling and aggregation—VEGFA—pancreatic cancer	4.01e-06	0.00058	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—ARG2—pancreatic cancer	3.99e-06	0.000577	CbGpPWpGaD
Rosiglitazone—PPARG—Developmental Biology—KRAS—pancreatic cancer	3.98e-06	0.000576	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—ARG2—pancreatic cancer	3.96e-06	0.000572	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—PRSS1—pancreatic cancer	3.9e-06	0.000564	CbGpPWpGaD
Rosiglitazone—ALB—Hemostasis—PLAU—pancreatic cancer	3.88e-06	0.000562	CbGpPWpGaD
Rosiglitazone—SLCO1B1—Metabolism—STK11—pancreatic cancer	3.88e-06	0.000562	CbGpPWpGaD
Rosiglitazone—ACSL4—Metabolism—AKT1—pancreatic cancer	3.87e-06	0.00056	CbGpPWpGaD
Rosiglitazone—PTGS1—Metabolism—CD44—pancreatic cancer	3.83e-06	0.000555	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism—TYMP—pancreatic cancer	3.79e-06	0.000549	CbGpPWpGaD
Rosiglitazone—PTGS1—Metabolism of lipids and lipoproteins—PIK3CB—pancreatic cancer	3.75e-06	0.000543	CbGpPWpGaD
Rosiglitazone—PTGS1—Metabolism of lipids and lipoproteins—PTGS2—pancreatic cancer	3.72e-06	0.000538	CbGpPWpGaD
Rosiglitazone—ALB—Platelet activation, signaling and aggregation—TGFB1—pancreatic cancer	3.68e-06	0.000532	CbGpPWpGaD
Rosiglitazone—PTGS1—Metabolism—GCG—pancreatic cancer	3.68e-06	0.000532	CbGpPWpGaD
Rosiglitazone—SLCO1B1—Metabolism of lipids and lipoproteins—PTEN—pancreatic cancer	3.65e-06	0.000527	CbGpPWpGaD
Rosiglitazone—CYP2A6—Metabolism—CD44—pancreatic cancer	3.62e-06	0.000524	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism of lipids and lipoproteins—APOE—pancreatic cancer	3.51e-06	0.000507	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—TYMP—pancreatic cancer	3.49e-06	0.000505	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism of lipids and lipoproteins—APOE—pancreatic cancer	3.49e-06	0.000504	CbGpPWpGaD
Rosiglitazone—CYP2A6—Metabolism—GCG—pancreatic cancer	3.48e-06	0.000503	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—TYMP—pancreatic cancer	3.46e-06	0.0005	CbGpPWpGaD
Rosiglitazone—ALB—Hemostasis—PIK3CG—pancreatic cancer	3.46e-06	0.0005	CbGpPWpGaD
Rosiglitazone—PTGS1—Metabolism—STK11—pancreatic cancer	3.46e-06	0.0005	CbGpPWpGaD
Rosiglitazone—PPARG—Metabolism—APOE—pancreatic cancer	3.45e-06	0.000499	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism—GLP1R—pancreatic cancer	3.42e-06	0.000495	CbGpPWpGaD
Rosiglitazone—ALB—Hemostasis—EGF—pancreatic cancer	3.42e-06	0.000494	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism—GLP1R—pancreatic cancer	3.41e-06	0.000493	CbGpPWpGaD
Rosiglitazone—PPARG—Developmental Biology—HRAS—pancreatic cancer	3.38e-06	0.00049	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—ARG2—pancreatic cancer	3.38e-06	0.000489	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism—DPYD—pancreatic cancer	3.37e-06	0.000487	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism—DPYD—pancreatic cancer	3.35e-06	0.000485	CbGpPWpGaD
Rosiglitazone—SLCO1B1—Metabolism—TYMS—pancreatic cancer	3.34e-06	0.000483	CbGpPWpGaD
Rosiglitazone—CYP2A6—Metabolism—STK11—pancreatic cancer	3.27e-06	0.000473	CbGpPWpGaD
Rosiglitazone—PPARG—Metabolism of lipids and lipoproteins—PIK3CA—pancreatic cancer	3.27e-06	0.000473	CbGpPWpGaD
Rosiglitazone—PTGS1—Metabolism of lipids and lipoproteins—PTEN—pancreatic cancer	3.24e-06	0.000469	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism—SLC2A2—pancreatic cancer	3.2e-06	0.000463	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism—SLC2A2—pancreatic cancer	3.18e-06	0.00046	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CG—pancreatic cancer	3.16e-06	0.000458	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism of lipids and lipoproteins—PIK3CG—pancreatic cancer	3.15e-06	0.000455	CbGpPWpGaD
Rosiglitazone—ALB—Platelet activation, signaling and aggregation—PIK3CA—pancreatic cancer	3.13e-06	0.000453	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism of lipids and lipoproteins—APOE—pancreatic cancer	3.13e-06	0.000453	CbGpPWpGaD
Rosiglitazone—PPARG—Metabolism—PIK3CG—pancreatic cancer	3.11e-06	0.000451	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism—GLP1R—pancreatic cancer	3.06e-06	0.000442	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—pancreatic cancer	3.05e-06	0.000442	CbGpPWpGaD
Rosiglitazone—ALB—Hemostasis—PIK3CD—pancreatic cancer	3.04e-06	0.000439	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism of lipids and lipoproteins—PPARG—pancreatic cancer	3.04e-06	0.000439	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism—DPYD—pancreatic cancer	3.01e-06	0.000435	CbGpPWpGaD
Rosiglitazone—PPARG—Developmental Biology—AKT1—pancreatic cancer	2.99e-06	0.000432	CbGpPWpGaD
Rosiglitazone—PTGS1—Metabolism—TYMS—pancreatic cancer	2.97e-06	0.00043	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—TYMP—pancreatic cancer	2.96e-06	0.000427	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism—SLC2A2—pancreatic cancer	2.85e-06	0.000413	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism of lipids and lipoproteins—APOE—pancreatic cancer	2.85e-06	0.000413	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CG—pancreatic cancer	2.82e-06	0.000409	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—GLP1R—pancreatic cancer	2.81e-06	0.000407	CbGpPWpGaD
Rosiglitazone—CYP2A6—Metabolism—TYMS—pancreatic cancer	2.81e-06	0.000407	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—GLP1R—pancreatic cancer	2.79e-06	0.000403	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CD—pancreatic cancer	2.78e-06	0.000402	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—DPYD—pancreatic cancer	2.77e-06	0.0004	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism of lipids and lipoproteins—PIK3CD—pancreatic cancer	2.77e-06	0.0004	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—DPYD—pancreatic cancer	2.74e-06	0.000397	CbGpPWpGaD
Rosiglitazone—PPARG—Metabolism—PIK3CD—pancreatic cancer	2.74e-06	0.000396	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—pancreatic cancer	2.73e-06	0.000394	CbGpPWpGaD
Rosiglitazone—SLCO1B1—Metabolism—APOE—pancreatic cancer	2.72e-06	0.000393	CbGpPWpGaD
Rosiglitazone—ALB—Hemostasis—PIK3CB—pancreatic cancer	2.65e-06	0.000383	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—SLC2A2—pancreatic cancer	2.62e-06	0.00038	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—SLC2A2—pancreatic cancer	2.6e-06	0.000376	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—pancreatic cancer	2.58e-06	0.000373	CbGpPWpGaD
Rosiglitazone—SLCO1B1—Metabolism of lipids and lipoproteins—PIK3CA—pancreatic cancer	2.57e-06	0.000372	CbGpPWpGaD
Rosiglitazone—ALB—Platelet activation, signaling and aggregation—AKT1—pancreatic cancer	2.56e-06	0.00037	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—pancreatic cancer	2.49e-06	0.00036	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CD—pancreatic cancer	2.48e-06	0.000359	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism—CD44—pancreatic cancer	2.48e-06	0.000358	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism—CD44—pancreatic cancer	2.46e-06	0.000356	CbGpPWpGaD
Rosiglitazone—SLCO1B1—Metabolism—PIK3CG—pancreatic cancer	2.45e-06	0.000355	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism of lipids and lipoproteins—APOE—pancreatic cancer	2.44e-06	0.000353	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CB—pancreatic cancer	2.42e-06	0.000351	CbGpPWpGaD
Rosiglitazone—PTGS1—Metabolism—APOE—pancreatic cancer	2.42e-06	0.00035	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism of lipids and lipoproteins—PIK3CB—pancreatic cancer	2.41e-06	0.000349	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—pancreatic cancer	2.4e-06	0.000348	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism of lipids and lipoproteins—PTGS2—pancreatic cancer	2.39e-06	0.000346	CbGpPWpGaD
Rosiglitazone—PPARG—Metabolism—PIK3CB—pancreatic cancer	2.39e-06	0.000345	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—GLP1R—pancreatic cancer	2.38e-06	0.000345	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism—GCG—pancreatic cancer	2.37e-06	0.000343	CbGpPWpGaD
Rosiglitazone—SLCO1B1—Metabolism—PPARG—pancreatic cancer	2.37e-06	0.000342	CbGpPWpGaD
Rosiglitazone—PPARG—Metabolism—PTGS2—pancreatic cancer	2.36e-06	0.000342	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism—GCG—pancreatic cancer	2.36e-06	0.000341	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—DPYD—pancreatic cancer	2.34e-06	0.000339	CbGpPWpGaD
Rosiglitazone—PTGS1—Metabolism of lipids and lipoproteins—PIK3CA—pancreatic cancer	2.29e-06	0.000331	CbGpPWpGaD
Rosiglitazone—CYP2A6—Metabolism—APOE—pancreatic cancer	2.29e-06	0.000331	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—pancreatic cancer	2.26e-06	0.000328	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism—STK11—pancreatic cancer	2.23e-06	0.000323	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—SLC2A2—pancreatic cancer	2.22e-06	0.000322	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism—STK11—pancreatic cancer	2.22e-06	0.000321	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism—CD44—pancreatic cancer	2.21e-06	0.00032	CbGpPWpGaD
Rosiglitazone—PPARG—Gene Expression—MYC—pancreatic cancer	2.2e-06	0.000319	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—pancreatic cancer	2.2e-06	0.000318	CbGpPWpGaD
Rosiglitazone—PTGS1—Metabolism—PIK3CG—pancreatic cancer	2.18e-06	0.000316	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CB—pancreatic cancer	2.16e-06	0.000313	CbGpPWpGaD
Rosiglitazone—SLCO1B1—Metabolism—PIK3CD—pancreatic cancer	2.16e-06	0.000312	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—pancreatic cancer	2.14e-06	0.00031	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—pancreatic cancer	2.12e-06	0.000307	CbGpPWpGaD
Rosiglitazone—ALB—Hemostasis—SRC—pancreatic cancer	2.12e-06	0.000307	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism—GCG—pancreatic cancer	2.12e-06	0.000307	CbGpPWpGaD
Rosiglitazone—PTGS1—Metabolism—PPARG—pancreatic cancer	2.11e-06	0.000305	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—pancreatic cancer	2.1e-06	0.000303	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism of lipids and lipoproteins—PTEN—pancreatic cancer	2.08e-06	0.000301	CbGpPWpGaD
Rosiglitazone—ALB—Hemostasis—VEGFA—pancreatic cancer	2.07e-06	0.000299	CbGpPWpGaD
Rosiglitazone—CYP2A6—Metabolism—PIK3CG—pancreatic cancer	2.06e-06	0.000298	CbGpPWpGaD
Rosiglitazone—PPARG—Metabolism—PTEN—pancreatic cancer	2.06e-06	0.000298	CbGpPWpGaD
Rosiglitazone—ALB—Hemostasis—NRAS—pancreatic cancer	2.04e-06	0.000295	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—CD44—pancreatic cancer	2.03e-06	0.000294	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—CD44—pancreatic cancer	2.02e-06	0.000292	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism—STK11—pancreatic cancer	1.99e-06	0.000288	CbGpPWpGaD
Rosiglitazone—CYP2A6—Metabolism—PPARG—pancreatic cancer	1.99e-06	0.000288	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—pancreatic cancer	1.97e-06	0.000285	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—pancreatic cancer	1.96e-06	0.000283	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—GCG—pancreatic cancer	1.95e-06	0.000282	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—pancreatic cancer	1.93e-06	0.00028	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—GCG—pancreatic cancer	1.93e-06	0.000279	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism—TYMS—pancreatic cancer	1.92e-06	0.000278	CbGpPWpGaD
Rosiglitazone—PTGS1—Metabolism—PIK3CD—pancreatic cancer	1.92e-06	0.000277	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism—TYMS—pancreatic cancer	1.91e-06	0.000276	CbGpPWpGaD
Rosiglitazone—ALB—Hemostasis—TGFB1—pancreatic cancer	1.9e-06	0.000274	CbGpPWpGaD
Rosiglitazone—SLCO1B1—Metabolism—PIK3CB—pancreatic cancer	1.88e-06	0.000272	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—pancreatic cancer	1.87e-06	0.000271	CbGpPWpGaD
Rosiglitazone—SLCO1B1—Metabolism—PTGS2—pancreatic cancer	1.86e-06	0.000269	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—STK11—pancreatic cancer	1.83e-06	0.000265	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—STK11—pancreatic cancer	1.82e-06	0.000263	CbGpPWpGaD
Rosiglitazone—CYP2A6—Metabolism—PIK3CD—pancreatic cancer	1.81e-06	0.000262	CbGpPWpGaD
Rosiglitazone—ALB—Hemostasis—KRAS—pancreatic cancer	1.76e-06	0.000254	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—CD44—pancreatic cancer	1.72e-06	0.000249	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism—TYMS—pancreatic cancer	1.71e-06	0.000248	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—pancreatic cancer	1.71e-06	0.000247	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—pancreatic cancer	1.69e-06	0.000244	CbGpPWpGaD
Rosiglitazone—PTGS1—Metabolism—PIK3CB—pancreatic cancer	1.67e-06	0.000242	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—pancreatic cancer	1.67e-06	0.000242	CbGpPWpGaD
Rosiglitazone—PTGS1—Metabolism—PTGS2—pancreatic cancer	1.66e-06	0.00024	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—GCG—pancreatic cancer	1.65e-06	0.000239	CbGpPWpGaD
Rosiglitazone—SLCO1B1—Metabolism—PTEN—pancreatic cancer	1.62e-06	0.000235	CbGpPWpGaD
Rosiglitazone—ALB—Hemostasis—PIK3CA—pancreatic cancer	1.61e-06	0.000234	CbGpPWpGaD
Rosiglitazone—CYP2A6—Metabolism—PIK3CB—pancreatic cancer	1.58e-06	0.000229	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—TYMS—pancreatic cancer	1.58e-06	0.000228	CbGpPWpGaD
Rosiglitazone—CYP2A6—Metabolism—PTGS2—pancreatic cancer	1.57e-06	0.000227	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—TYMS—pancreatic cancer	1.56e-06	0.000226	CbGpPWpGaD
Rosiglitazone—ALB—Hemostasis—TP53—pancreatic cancer	1.56e-06	0.000226	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism—APOE—pancreatic cancer	1.56e-06	0.000226	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism—APOE—pancreatic cancer	1.55e-06	0.000225	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—STK11—pancreatic cancer	1.55e-06	0.000225	CbGpPWpGaD
Rosiglitazone—PPARG—Gene Expression—AKT1—pancreatic cancer	1.53e-06	0.000221	CbGpPWpGaD
Rosiglitazone—ALB—Hemostasis—HRAS—pancreatic cancer	1.49e-06	0.000216	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—pancreatic cancer	1.48e-06	0.000214	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism of lipids and lipoproteins—PIK3CA—pancreatic cancer	1.47e-06	0.000213	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—pancreatic cancer	1.46e-06	0.000211	CbGpPWpGaD
Rosiglitazone—PPARG—Metabolism—PIK3CA—pancreatic cancer	1.45e-06	0.00021	CbGpPWpGaD
Rosiglitazone—PTGS1—Metabolism—PTEN—pancreatic cancer	1.44e-06	0.000209	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism—PIK3CG—pancreatic cancer	1.41e-06	0.000204	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism—PIK3CG—pancreatic cancer	1.4e-06	0.000203	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism—APOE—pancreatic cancer	1.39e-06	0.000202	CbGpPWpGaD
Rosiglitazone—CYP2A6—Metabolism—PTEN—pancreatic cancer	1.37e-06	0.000198	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism—PPARG—pancreatic cancer	1.36e-06	0.000197	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism—PPARG—pancreatic cancer	1.35e-06	0.000196	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—TYMS—pancreatic cancer	1.34e-06	0.000193	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—pancreatic cancer	1.32e-06	0.000191	CbGpPWpGaD
Rosiglitazone—ALB—Hemostasis—AKT1—pancreatic cancer	1.32e-06	0.000191	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—APOE—pancreatic cancer	1.28e-06	0.000185	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—APOE—pancreatic cancer	1.27e-06	0.000184	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism—PIK3CG—pancreatic cancer	1.26e-06	0.000182	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism—PIK3CD—pancreatic cancer	1.24e-06	0.000179	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism—PIK3CD—pancreatic cancer	1.23e-06	0.000178	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism—PPARG—pancreatic cancer	1.21e-06	0.000176	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—pancreatic cancer	1.2e-06	0.000174	CbGpPWpGaD
Rosiglitazone—PPARG—Metabolism—AKT1—pancreatic cancer	1.19e-06	0.000172	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—PIK3CG—pancreatic cancer	1.16e-06	0.000167	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—PIK3CG—pancreatic cancer	1.15e-06	0.000166	CbGpPWpGaD
Rosiglitazone—SLCO1B1—Metabolism—PIK3CA—pancreatic cancer	1.15e-06	0.000166	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—PPARG—pancreatic cancer	1.12e-06	0.000162	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—PPARG—pancreatic cancer	1.11e-06	0.00016	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism—PIK3CD—pancreatic cancer	1.11e-06	0.00016	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—APOE—pancreatic cancer	1.09e-06	0.000157	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism—PIK3CB—pancreatic cancer	1.08e-06	0.000156	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism—PIK3CB—pancreatic cancer	1.07e-06	0.000155	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism—PTGS2—pancreatic cancer	1.07e-06	0.000155	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism—PTGS2—pancreatic cancer	1.06e-06	0.000154	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—pancreatic cancer	1.03e-06	0.000149	CbGpPWpGaD
Rosiglitazone—PTGS1—Metabolism—PIK3CA—pancreatic cancer	1.02e-06	0.000147	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—PIK3CD—pancreatic cancer	1.02e-06	0.000147	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—PIK3CD—pancreatic cancer	1.01e-06	0.000146	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—PIK3CG—pancreatic cancer	9.8e-07	0.000142	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism—PIK3CB—pancreatic cancer	9.64e-07	0.000139	CbGpPWpGaD
Rosiglitazone—CYP2A6—Metabolism—PIK3CA—pancreatic cancer	9.64e-07	0.000139	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism—PTGS2—pancreatic cancer	9.55e-07	0.000138	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—PPARG—pancreatic cancer	9.46e-07	0.000137	CbGpPWpGaD
Rosiglitazone—SLCO1B1—Metabolism—AKT1—pancreatic cancer	9.36e-07	0.000135	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism—PTEN—pancreatic cancer	9.33e-07	0.000135	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism—PTEN—pancreatic cancer	9.28e-07	0.000134	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—PIK3CB—pancreatic cancer	8.86e-07	0.000128	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—PIK3CB—pancreatic cancer	8.79e-07	0.000127	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—PTGS2—pancreatic cancer	8.78e-07	0.000127	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—PTGS2—pancreatic cancer	8.71e-07	0.000126	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—PIK3CD—pancreatic cancer	8.62e-07	0.000125	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism—PTEN—pancreatic cancer	8.33e-07	0.00012	CbGpPWpGaD
Rosiglitazone—PTGS1—Metabolism—AKT1—pancreatic cancer	8.32e-07	0.00012	CbGpPWpGaD
Rosiglitazone—CYP2A6—Metabolism—AKT1—pancreatic cancer	7.87e-07	0.000114	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—PTEN—pancreatic cancer	7.66e-07	0.000111	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—PTEN—pancreatic cancer	7.59e-07	0.00011	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—PIK3CB—pancreatic cancer	7.51e-07	0.000109	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—PTGS2—pancreatic cancer	7.44e-07	0.000108	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism—PIK3CA—pancreatic cancer	6.58e-07	9.52e-05	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism—PIK3CA—pancreatic cancer	6.55e-07	9.47e-05	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—PTEN—pancreatic cancer	6.49e-07	9.39e-05	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism—PIK3CA—pancreatic cancer	5.88e-07	8.5e-05	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—PIK3CA—pancreatic cancer	5.4e-07	7.82e-05	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism—AKT1—pancreatic cancer	5.38e-07	7.78e-05	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—PIK3CA—pancreatic cancer	5.36e-07	7.75e-05	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism—AKT1—pancreatic cancer	5.35e-07	7.73e-05	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism—AKT1—pancreatic cancer	4.8e-07	6.94e-05	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—PIK3CA—pancreatic cancer	4.58e-07	6.62e-05	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—AKT1—pancreatic cancer	4.41e-07	6.39e-05	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—AKT1—pancreatic cancer	4.38e-07	6.33e-05	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—AKT1—pancreatic cancer	3.74e-07	5.41e-05	CbGpPWpGaD
